Lamotrigine Tablet, Extended Release
Product Images NDC 55111-720

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55111-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Lamotrigine Extended-Release Tablets USP, 25 mg, oral dosage form in a bottle label displaying 30 tablets container. The label includes warnings to verify the product dispensed and instructs pharmacists to dispense the accompanying medication guide to each patient. Manufactured by Dr. Reddy's Laboratories Limited.*

FDA Label Image

Container2 (Container2)

The packaging label for Lamotrigine Extended-Release Tablets USP, 50 mg, oral tablets in a 30-count bottle. The label indicates the product is for Rx only and distributed by Dr. Reddy's Laboratories Limited. The label includes usage instructions, a caution to verify product dispensed, the NDC number 55111-718-30, and a barcode.*

FDA Label Image

Container3 (Container3)

Lamotrigine Extended-Release Tablets 100 mg in a blister strip containing 30 tablets by Dr. Reddy's Laboratories Limited. The label includes the NDC 55111-719-30 and a cautionary note to verify product dispensing and provide the Medication Guide to patients. The packaging also shows storage instructions and a barcode.*

FDA Label Image

Container4 (Container4)

Lamotrigine Extended-Release Tablets USP 200 mg label by Dr. Reddy's Laboratories Limited. The label indicates a 30-count bottle of oral extended-release tablets, displaying the product name, strength, quantity, and manufacturer details. It includes a caution to verify the product dispensed and pharmacy instructions for medication guides.*

FDA Label Image

Container5

Lamotrigine Extended-Release Tablets USP 250 mg carton label from Dr. Reddy's Laboratories Limited. The label states a package size of 30 extended-release tablets with a 250 mg strength. Includes instructions to verify the dispensed product and pharmacist guidance to provide the medication guide to each patient. The route of administration is oral.*

FDA Label Image

Container6 (Container6)

Lamotrigine Extended-Release Tablets USP, 300 mg, oral dosage form, with a pack size of 30 tablets. The label includes the NDC 55111-428-30, indicates once-a-day dosing, and is labeled for prescription use only. Manufactured by Dr. Reddy's Laboratories Limited, the label features a caution to verify the product dispensed and instructions for pharmacists to provide an accompanying medication guide.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing responder rates between Lamotrigine extended-release tablets and placebo. The x-axis represents the percent of patients from 0 to 100, and the y-axis shows responder rate from worsening (-100%) to improvement (100%). Two curves illustrate responder rates for placebo (dashed line, N=73) and Lamotrigine ER tablets (solid line, N=70).*

FDA Label Image

Figure2 (Figure2)

A responder rate curve comparing placebo and Lamotrigine extended-release tablets in patients. The Y-axis shows responder rate from -100% (worsening) to 100% (improvement), and the X-axis represents the percent of patients from 0 to 100. The solid line represents Lamotrigine extended-release tablets (116 patients), while the dashed line represents placebo (120 patients).*

FDA Label Image

Pictures (Pictures)

Lamotrigine extended release oral tablets in multiple strengths and colors: 25 mg yellow round biconvex, 50 mg light green round biconvex, 100 mg orange round biconvex, 200 mg blue round biconvex, 250 mg purple oval biconvex, and 300 mg grey capsule-shaped biconvex. Each tablet is imprinted with a distinct code on one side and is plain on the other. Labeler: Dr.Reddy's Laboratories Limited.*

FDA Label Image

Structure (Structure)

Chemical structure of lamotrigine, depicting its molecular arrangement including chlorine atoms, amino groups, and a triazine ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.